| Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels (NCT01138514) | Padagis LLC | 2009-10-01 |
| A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris (NCT01016977) | Stiefel, a GSK Company | 2009-10-01 |
| A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne (NCT01017120) | Stiefel, a GSK Company | 2009-10-01 |
| A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 (NCT01017146) | Stiefel, a GSK Company | 2009-10-01 |
| The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage (NCT00991198) | Aria Aesthetics Inc. | 2009-09-01 |
| 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne (NCT02524665) | Stiefel, a GSK Company | 2009-09-01 |
| U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ (NCT01706250) | Stiefel, a GSK Company | 2009-09-01 |
| U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne (NCT01706263) | Stiefel, a GSK Company | 2009-08-01 |
| Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) (NCT00933543) | Photocure | 2009-08-01 |
| Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications (NCT01015638) | Stiefel, a GSK Company | 2009-08-01 |
| Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris (NCT01014689) | Galderma R&D | 2009-08-01 |
| Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications (NCT00964366) | Stiefel, a GSK Company | 2009-07-01 |
| A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne (NCT00964223) | Stiefel, a GSK Company | 2009-07-01 |
| Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face (NCT00952523) | Bausch Health Americas, Inc. | 2009-07-01 |
| Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications (NCT00926367) | Stiefel, a GSK Company | 2009-05-01 |
| MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (NCT01050465) | University of Missouri-Columbia | 2009-05-01 |
| A Novel Method to Improve Acne Outcomes (NCT01176955) | Wake Forest University | 2009-05-01 |
| Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne (NCT00722761) | Massachusetts General Hospital | 2009-04-01 |
| A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash (NCT00891982) | Stiefel, a GSK Company | 2009-04-01 |
| Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face (NCT00919191) | Bausch Health Americas, Inc. | 2009-04-01 |
| Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II (NCT00877409) | Zurita Laboratorio Farmaceutico Ltda. | 2009-04-01 |
| Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel (NCT01095640) | Actavis Mid-Atlantic LLC | 2009-03-01 |
| Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris (NCT01047189) | Wake Forest University | 2009-03-01 |
| Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate (NCT00838812) | Igefarma Laboratorios S.A. | 2009-03-01 |
| A Study of Acne Treatment in Children Ages 9 to 11 (NCT00907335) | Bausch Health Americas, Inc. | 2009-02-01 |
| A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne (NCT00887484) | Stiefel, a GSK Company | 2009-02-01 |
| Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris (NCT00814918) | University of Chicago | 2009-02-01 |
| A Study of Different Use Regimens Using Two Acne Treatments (NCT00907257) | Bausch Health Americas, Inc. | 2009-02-01 |
| W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers (NCT01929278) | Stiefel, a GSK Company | 2008-12-08 |
| Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris (NCT00834210) | Allergan | 2008-12-01 |
| Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris (NCT00835198) | Allergan | 2008-12-01 |
| An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment (NCT01466673) | Janssen-Cilag Ltd.,Thailand | 2008-12-01 |
| W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers (NCT01915758) | GlaxoSmithKline | 2008-11-21 |
| Pulsed Dye Laser Treatment of Acne Vulgaris (NCT01052246) | Laserklinik Karlsruhe | 2008-10-01 |
| Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring (NCT00795327) | Bausch Health Americas, Inc. | 2008-10-01 |
| Efficacy of Silk - Like Bedding Fabric Pillow Case in the Treatment of Acne Vulgaris (NCT00767104) | Wake Forest University | 2008-10-01 |
| Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne (NCT00776919) | Stiefel, a GSK Company | 2008-10-01 |
| A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions (NCT01160757) | Arizona State University | 2008-10-01 |
| Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris (NCT00757523) | Stiefel, a GSK Company | 2008-09-10 |
| A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory (NCT01404130) | University of Aberdeen | 2008-09-01 |
| Comparison of Nadifloxacin Cream Alone and With Benzoyl Peroxide Solution in the Treatment of Acne (NCT00869492) | Marmara University | 2008-08-01 |
| Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne (NCT00713609) | Stiefel, a GSK Company | 2008-06-01 |
| Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris (NCT00673933) | Photocure | 2008-05-01 |
| Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris (NCT00787943) | Northwestern University | 2008-05-01 |
| Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% (NCT00660985) | Galderma R&D | 2008-05-01 |
| A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel (NCT00689117) | Stiefel, a GSK Company | 2008-04-01 |
| Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate (NCT00635609) | Warner Chilcott | 2008-03-01 |
| Comparison of Two Salicylic Acid Formulations (NCT00848744) | Northwestern University | 2008-02-01 |
| Treatment of Moderate to Severe Facial Acne Vulgaris (NCT00612573) | Warner Chilcott | 2008-02-01 |
| Photodynamic Therapy in the Treatment of Acne (NCT00613444) | University of Michigan | 2008-02-01 |
| A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris (NCT00666900) | Dow Pharmaceutical Sciences | 2008-01-01 |
| Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. (NCT00714714) | Bausch Health Americas, Inc. | 2008-01-01 |
| Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris (NCT00671749) | Galderma R&D | 2007-12-01 |
| Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations (NCT01044264) | Padagis LLC | 2007-12-01 |
| Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% (NCT00598832) | Galderma R&D | 2007-11-01 |
| Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% (NCT00599521) | Galderma R&D | 2007-11-01 |
| Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris (NCT00829049) | Allergan | 2007-10-01 |
| Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris (NCT00558831) | Northwestern University | 2007-10-01 |
| Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne (NCT00392223) | Pfizer | 2007-10-01 |
| Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris (NCT01182636) | Teva Pharmaceuticals USA | 2007-07-01 |
| Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne (NCT00706433) | DUSA Pharmaceuticals, Inc. | 2007-03-01 |
| Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris (NCT00441415) | Galderma R&D | 2007-02-01 |
| Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne (NCT00594425) | Photocure | 2007-02-01 |
| Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne (NCT00807014) | Stiefel, a GSK Company | 2006-11-01 |
| The Treatment of Acne Vulgaris With Radiofrequency Device (NCT00441805) | Alma Lasers | 2006-11-01 |
| A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris (NCT00663286) | Dow Pharmaceutical Sciences | 2006-10-01 |
| A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris (NCT00664248) | Dow Pharmaceutical Sciences | 2006-10-01 |
| A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris (NCT00421993) | Galderma R&D | 2006-10-01 |
| Microdermabrasion for Acne (NCT00355485) | University of Michigan | 2006-09-01 |
| Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris (NCT00422240) | Galderma R&D | 2006-06-27 |
| Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris (NCT00696449) | Wake Forest University | 2006-06-01 |
| Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris (NCT00624676) | Cosmetique Active International | 2006-01-01 |
| Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency (NCT00243542) | Allergan | 2005-11-01 |
| The Development and Evaluation of an "E-Visit" Program for the Management of Acne (NCT00417456) | Massachusetts General Hospital | 2005-10-01 |
| Non-cutting Laser Therapy in the Treatment of Acne (NCT00113425) | University of Michigan | 2005-08-01 |
| EGCG Improves Acne by Modulating Molecular Targets (NCT01687556) | Seoul National University Hospital | 2005-07-01 |
| Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris (NCT00361322) | Hadassah Medical Organization | 2005-04-01 |
| A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% (NCT00151541) | Allergan | 2005-02-01 |
| Dalacin-T Gel Post Approval Study (NCT00219570) | Pfizer | 2005-01-01 |
| Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris (NCT00160394) | Stiefel, a GSK Company | 2004-12-01 |
| Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris (NCT00098358) | Critical Therapeutics | 2004-11-01 |
| Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study (NCT00206895) | Bispebjerg Hospital | 2004-11-01 |
| Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris (NCT00752635) | Johnson & Johnson Taiwan Ltd | 2004-09-01 |
| Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa (NCT00280657) | Bayer | 2004-03-10 |
| Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects (NCT00446043) | Galderma R&D | 2004-02-17 |
| Infrared Non-Cutting Laser Therapy for Acne (NCT00110643) | University of Michigan | 2003-02-01 |
| Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne. (NCT00651469) | Bayer | 2003-01-01 |
| Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne (NCT00211497) | BioWest Therapeutics Inc | 2003-01-01 |
| Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne (NCT00656981) | Bayer | 2003-01-01 |
| Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris (NCT00145106) | KGL, Inc. | 2002-03-01 |
| Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne (NCT00211523) | BioWest Therapeutics Inc | 2000-10-01 |
| 5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris (NCT00714454) | University of Miami | |
| Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris (NCT02716090) | Ache Laboratorios Farmaceuticos S.A. | |